Nature9d
Environmental monitoring articles from across Nature Portfolio
Environmental monitoring is the repeated measurement of physical, chemical and biological variables in order to study environmental changes, particularly those arising from human activities.
poncacitynow16d
FDA Expands Approval for Antidepressant Nasal Spray
The Food and Drug Administration (FDA) recently expanded approval for Spravato, an antidepressant nasal spray used to treat depression. Parkside Psychiatric Hospital has a Spravato outpatient clinic ...
'It changed my life tremendously': P.E.I.'s new ketamine clinic could offer mental health help
Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with depression and suicidal thoughts- especially when anti-depressants and talk ...
News917d
FDA expands approval for antidepressant nasal spray
Patients using Spravato need to stay in a secluded area for 2 hours after taking the medication to monitor for side effects. To qualify for treatment, patients must have a referral from a doctor ...
IGN21d
Here Are the Best Monitor Deals from Dell and Alienware (Save on Both Productivity and Gaming Monitors)
See below for our favorite picks. The best gaming monitor from Dell in terms of value is the 34" Dell S3422DWG ultra-wide gaming monitor, and it's down to the lowest price ever. In fact ...
Pharm Exec21d
Spravato’s Transformative Impact: Offering Hope and Rapid Relief for Patients with Depression
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the immediate impact Spravato has had on patients with treatment-resistant ...
Fortune22d
FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment
An estimated 21 million American adults suffer from clinical depression. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...
ENDPOINTS NEWS23d
Ahead of earn­ings, Lil­ly culls mid-stage drug for heart fail­ure and chron­ic kid­ney dis­ease
Eli Lil­ly is dis­con­tin­u­ing a Phase 2 re­lax­in treat­ment can­di­date for heart fail­ure and chron­ic kid­ney dis­ease, a spokesper­son for the com­pa­ny con­firmed to … ...
Pharm Exec23d
New Spravato Indication Offers Greater Flexibility and Personalization for Patients with Treatment-Resistant Depression
Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the approval of Spravato for treatment-resistant depression. PE: How does ...
verywellhealth23d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
AOL24d
FDA-approved nasal spray for severe depression can lead to remission
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...
Renal & Urology News24d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
Drug is the first and only approved monotherapy for refractory major depressive disorder. (HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...